Sector
PharmaceuticalsOpen
₹155Prev. Close
₹159.4Turnover(Lac.)
₹0.25Day's High
₹156.75Day's Low
₹151.6552 Week's High
₹269.7552 Week's Low
₹78Book Value
₹32.17Face Value
₹10Mkt Cap (₹ Cr.)
99.77P/E
39.26EPS
4.06Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 6.44 | 6.44 | 6.44 | 6.44 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.02 | 11.28 | 9.16 | 6.73 |
Net Worth | 19.46 | 17.72 | 15.6 | 13.17 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 24.87 | 13.59 | 12.8 | 10.83 |
yoy growth (%) | 83.06 | 6.11 | 18.16 | -32 |
Raw materials | -9.91 | -4.85 | -4.8 | -3.94 |
As % of sales | 39.84 | 35.72 | 37.54 | 36.38 |
Employee costs | -2.53 | -2.41 | -2.25 | -2 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 4.04 | 1.84 | 1.05 | 0.83 |
Depreciation | -0.36 | -0.33 | -0.33 | -0.34 |
Tax paid | -0.65 | -0.2 | -0.02 | -0.03 |
Working capital | 1.48 | 2.04 | -0.55 | 0.24 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 83.06 | 6.11 | 18.16 | -32 |
Op profit growth | 79.81 | 49.87 | 12.03 | -23.81 |
EBIT growth | 106.34 | 65.14 | 16.47 | -28.8 |
Net profit growth | 105.76 | 59.76 | 28.15 | -42.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
NARAYANAN NARASIMHAN
Managing Director
Arvind Varchaswi N
Whole Time Director
Tejagna Kashmira Katpitia
Independent Director
CHANDRAKANT LAXMINARAYAN RATHI
Company Sec. & Compli. Officer
Yash Jain
Independent Director
Puvan Sripathy
Independent Director
Commodore H G Harsha
Independent Director
Prasana Prabhu
Independent Director
Romila Sen
Non Executive Director
Sturle Harald Pedersen
Non Executive Director
Jeewan Prakash Gupta
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Source Natural Foods & Herbal Supplements Ltd
Summary
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12. The Company engages in the pharmaceutical business in India. It provides allopathic and ayurvedic formulations. Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country. Company focuses on such products which will bring Ayurveda in to individuals daily diet. It provide various Ayurvedic products in the form of medicines and herbal supplements. It focuses on ongoing R & D, which helps it to achieve its core objectives to bring more herbal and organic products in to the existing/ new product portfolio and to add more value to the existing products and develop organic food and nutritional supplements with an optimum mix of naturally available ingredients for attaining a sustainable improvement in the Health of all age Groups.In 2000, the Company hived-off the bulk drug unit and diversified into software related activities by changing the Main Clause. In 2001, it signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization. The factory, located at Hyderabad in Andhra Pradesh, was completely shut down since
Read More
The Source Natural Foods & Herbal Supplements Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹155 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Source Natural Foods & Herbal Supplements Ltd is ₹99.77 Cr. as of 09 May ‘25
The PE and PB ratios of Source Natural Foods & Herbal Supplements Ltd is 39.26 and 4.95 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Source Natural Foods & Herbal Supplements Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Source Natural Foods & Herbal Supplements Ltd is ₹78 and ₹269.75 as of 09 May ‘25
Source Natural Foods & Herbal Supplements Ltd's CAGR for 5 Years at 20.27%, 3 Years at 21.01%, 1 Year at 83.07%, 6 Month at -35.86%, 3 Month at -7.41% and 1 Month at -13.23%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.